HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Peter Heydemann Selected Research
Peter Heydemann Research Topics
Disease
2
Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2022 - 01/2017
2
Congenital Toxoplasmosis
12/2011 - 05/2006
1
Retinal Diseases
01/2022
1
Neurodevelopmental Disorders
01/2020
1
Rett Syndrome (Rett's Disorder)
01/2020
1
Optic Atrophy
12/2017
1
Mitochondrial Diseases (Mitochondrial Disease)
12/2017
1
Heart Failure
10/2015
1
Neurologic Manifestations (Neurological Manifestations)
03/2012
1
Toxoplasmosis
12/2011
Drug/Important Bio-Agent (IBA)
2
Pyrimethamine (Daraprim)
FDA Link
03/2012 - 05/2006
2
Sulfadiazine (Sulphadiazine)
FDA Link
03/2012 - 05/2006
1
eteplirsen
IBA
01/2022
1
Methyl-CpG-Binding Protein 2
IBA
01/2020
1
Oxidoreductases (Dehydrogenase)
IBA
12/2017
1
Ferredoxin-NADP Reductase (Adrenodoxin Reductase)
IBA
12/2017
1
Cytochrome P-450 Enzyme System (Cytochrome P450)
IBA
12/2017
1
Flavoproteins
IBA
12/2017
1
NADP (NADPH)
IBA
12/2017
1
Adenosine Triphosphate (ATP)
IBA
12/2017
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
12/2017
1
Ferredoxins (Ferredoxin)
IBA
12/2017
1
ataluren
IBA
01/2017
1
Nonsense Codon (Nonsense Mutation)
IBA
01/2017
1
Vaccines
IBA
12/2011
1
Antibodies
IBA
12/2011
Therapy/Procedure
2
Therapeutics
10/2015 - 05/2006
1
Ventriculoperitoneal Shunt
01/2022